UBS AM’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.09M | Buy |
233,675
+36,714
| +19% | +$485K | ﹤0.01% | 1702 |
|
|
2026
Q1 | $3.24M | Buy |
196,961
+10,842
| +6% | +$266K | ﹤0.01% | 1796 |
|
|
2025
Q4 | $5.32M | Buy |
186,119
+1,914
| +1% | +$51.9K | ﹤0.01% | 1435 |
|
|
2025
Q3 | $5.42M | Sell |
184,205
-82,112
| -31% | -$2.24M | ﹤0.01% | 1334 |
|
|
2025
Q2 | $7.68M | Buy |
266,317
+37,919
| +17% | +$1.12M | ﹤0.01% | 1488 |
|
|
2025
Q1 | $7.99M | Buy |
228,398
+21,968
| +11% | +$896K | ﹤0.01% | 1333 |
|
|
2024
Q4 | $9.2M | Buy |
206,430
+48,846
| +31% | +$2M | ﹤0.01% | 1290 |
|
|
2024
Q3 | $7.19M | Buy |
157,584
+2,385
| +2% | +$96.5K | ﹤0.01% | 1381 |
|
|
2024
Q2 | $5.16M | Buy |
155,199
+53,851
| +53% | +$2.2M | ﹤0.01% | 1462 |
|
|
2024
Q1 | $4.86M | Buy |
101,348
+8,471
| +9% | +$494K | ﹤0.01% | 1268 |
|
|
2023
Q4 | $6.85M | Buy |
92,877
+800
| +0.9% | +$54.1K | ﹤0.01% | 1128 |
|
|
2023
Q3 | $6.73M | Buy |
92,077
+145
| +0.2% | +$11.6K | ﹤0.01% | 1107 |
|
|
2023
Q2 | $8.19M | Hold |
91,932
| – | – | ﹤0.01% | 1040 |
|
|
2023
Q1 | $8.19M | Buy |
91,932
+6,100
| +7% | +$531K | ﹤0.01% | 1040 |
|
|
2022
Q4 | $7.35M | Buy |
85,832
+2,148
| +3% | +$182K | ﹤0.01% | 1046 |
|
|
2022
Q3 | $5.98M | Sell |
83,684
-16,801
| -17% | -$1.5M | ﹤0.01% | 1140 |
|
|
2022
Q2 | $9.77M | Buy |
100,485
+29,605
| +42% | +$3.02M | 0.01% | 966 |
|
|
2022
Q1 | $7.97M | Buy |
70,880
+2,882
| +4% | +$307K | ﹤0.01% | 1162 |
|
|
2021
Q4 | $9.18M | Buy |
67,998
+970
| +1% | +$135K | ﹤0.01% | 1158 |
|
|
2021
Q3 | $9.46M | Buy |
67,028
+2,165
| +3% | +$291K | ﹤0.01% | 1113 |
|
|
2021
Q2 | $8.31M | Buy |
64,863
+3,015
| +5% | +$355K | ﹤0.01% | 1182 |
|
|
2021
Q1 | $7.91M | Sell |
61,848
-955
| -2% | -$176K | ﹤0.01% | 1159 |
|
|
2020
Q4 | $11.3M | Buy |
62,803
+7,430
| +13% | +$1.65M | 0.01% | 1016 |
|
|
2020
Q3 | $12.1M | Buy |
55,373
+3,557
| +7% | +$794K | 0.01% | 889 |
|
|
2020
Q2 | $11.6M | Buy |
51,816
+14,513
| +39% | +$2.27M | 0.01% | 867 |
|
|
2020
Q1 | $3.65M | Sell |
37,303
-452
| -1% | -$36.6K | ﹤0.01% | 1172 |
|
|
2019
Q4 | $2.83M | Buy |
37,755
+2,719
| +8% | +$176K | ﹤0.01% | 1447 |
|
|
2019
Q3 | $2.15M | Buy |
35,036
+9,344
| +36% | +$562K | ﹤0.01% | 1589 |
|
|
2019
Q2 | $1.52M | Buy |
25,692
+1,742
| +7% | +$104K | ﹤0.01% | 1721 |
|
|
2019
Q1 | $1.57M | Buy |
23,950
+6,512
| +37% | +$394K | ﹤0.01% | 1636 |
|
|
2018
Q4 | $851K | Sell |
17,438
-1,719
| -9% | -$103K | ﹤0.01% | 1818 |
|
|
2018
Q3 | $1.25M | Buy |
19,157
+3,070
| +19% | +$215K | ﹤0.01% | 1720 |
|
|
2018
Q2 | $1.07M | Buy |
16,087
+2,947
| +22% | +$178K | ﹤0.01% | 1795 |
|
|
2018
Q1 | $681K | Hold |
13,140
| – | – | ﹤0.01% | 1906 |
|
|
2017
Q4 | $570K | Buy |
13,140
+8,341
| +174% | +$341K | ﹤0.01% | 1928 |
|
|
2017
Q3 | $210K | Buy |
+4,799
| New | +$167K | ﹤0.01% | 2238 |
|
|
2016
Q4 | – | Sell |
-13,699
| Closed | -$303K | – | 2619 |
|
|
2016
Q3 | $303K | Hold |
13,699
| – | – | ﹤0.01% | 2260 |
|
|
2016
Q2 | $245K | Hold |
13,699
| – | – | ﹤0.01% | 2329 |
|
|
2016
Q1 | $236K | Sell |
13,699
-1,000
| -7% | -$16.7K | ﹤0.01% | 2346 |
|
|
2015
Q4 | $312K | Hold |
14,699
| – | – | ﹤0.01% | 2319 |
|
|
2015
Q3 | $278K | Hold |
14,699
| – | – | ﹤0.01% | 2323 |
|
|
2015
Q2 | $337K | Buy |
14,699
+400
| +3% | +$9.31K | ﹤0.01% | 2294 |
|
|
2015
Q1 | $386K | Buy |
14,299
+2,400
| +20% | +$61.2K | ﹤0.01% | 2116 |
|
|
2014
Q4 | $344K | Hold |
11,899
| – | – | ﹤0.01% | 2142 |
|
|
2014
Q3 | $320K | Hold |
11,899
| – | – | ﹤0.01% | 2112 |
|
|
2014
Q2 | $263K | Hold |
11,899
| – | – | ﹤0.01% | 2260 |
|
|
2014
Q1 | $325K | Buy |
11,899
+900
| +8% | +$26.3K | ﹤0.01% | 2135 |
|
|
2013
Q4 | $340K | Sell |
10,999
-1,200
| -10% | -$30.8K | ﹤0.01% | 2038 |
|
|
2013
Q3 | $346K | Sell |
12,199
-1,700
| -12% | -$46.4K | ﹤0.01% | 1996 |
|
|
2013
Q2 | $355K | Buy |
+13,899
| New | +$326K | ﹤0.01% | 1886 |
|
Other funds holding QDEL
NM
RCMNY
UBS AM's QDEL Position: Q2 2026 in Review
UBS AM increased its QuidelOrtho (QDEL) stake by 19% in Q2 2026, buying an estimated $485K and bringing the position to 233,675 shares worth $4.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.
UBS AM first reported a position in QDEL in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.1M in Q3 2020. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.
- UBS AM held 233,675 shares of QuidelOrtho worth $4.09M as of Q2 2026.
- UBS AM bought 36,714 QuidelOrtho shares in Q2 2026, an estimated $485K.
- QuidelOrtho made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1702 holding.
- UBS AM first reported a position in QuidelOrtho in Q2 2013 and has held it in 50 quarters since.
- UBS AM's QuidelOrtho position peaked at $12.1M in Q3 2020.
- 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.